ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research
December 23 2024 - 7:15AM
Business Wire
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence
and clinical research organisation, has been honoured with numerous
awards in the second half of 2024.
On TIME Magazine’s 2024 list of World’s Best Companies ICON was
ranked as the highest clinical research organisation out of 1,000
companies for the second year in a row, and in its 2025 list of
World’s Best Companies in Sustainable Growth it was featured at
number 57 out of 500 companies. ICON was also announced as a winner
of the Best Practices Recognition award from the Frost and Sullivan
Institute’s Enlightened Growth Leadership awards.
ICON was also honoured with a 2024 Scrip award for Best Contract
Research Organisation (Full Service Providers). These awards
acknowledge the critical role of CROs in delivering specialist
outsourced services for all aspects of clinical trials. This is the
fifth time ICON has won this coveted industry award in the last
eight years.
Two members of ICON’s executive leadership team were
acknowledged for professional accomplishment. Barry Balfe was named
to the 2024 PharmaVoice 100 List, which recognises the most
inspiring leaders in life sciences. Rose Kidd was announced as the
recipient of the Businesswoman Award at the 2024 Women Mean
Business Awards in Ireland. Additionally, Alexander Murray, an ICON
validation specialist, was named IRT Young Professional 2024 at
this year’s annual Interactive Response Technology (IRT)
Professionals’ Day, celebrating IRT and clinical supply excellence
across the industry.
ICON was also recognised across a range of creative and digital
marketing awards. Its Creative & Digital Services and Patient
Recruitment Services teams won two Health + Wellness awards from
Graphic Design USA for the TANGO and ADAMANT study materials, and a
Gold Award and Honourable Mention at the MarCom Awards for the same
studies in the in the category of “Strategic Communications |
Communications/Public Relations | Research/Study.” The MarCom
Awards further awarded ICON a Platinum honour for the UCB BE OPEN
Study Materials in the same category. ICON also received the Rx
Club Show Award of Excellence in the “Direct to Consumer”
category.
ICON’s FIRECREST medical animation video, “The Invisible
Machine,” won a gold MUSE award whilst at the 2024 Annual
International Business Awards, ICON won two Stevie® Awards: Gold
for a technology video showcasing AI platforms and wearables, and
Bronze for the CARD system, which enhances clinical data
distribution. At the 2024 Awards for Technical Excellence, ICON
also won a Silver Stevie® for eClinical Development &
Delivery’s tokenisation solution.
Steve Cutler, CEO, ICON commented: “It’s fantastic to end the
year with recognition for both individual employees as well as ICON
as a company. I’m incredibly proud of all the teams and individuals
who were honoured in these awards, which demonstrate ICON’s
commitment to delivering value and quality in the field of clinical
research.”
A full list of ICON’s industry awards can be viewed at
www.iconplc.com/awards.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical
research organisation. From molecule to medicine, we advance
clinical research providing outsourced services to pharmaceutical,
biotechnology, medical device and government and public health
organisations. We develop new innovations, drive emerging therapies
forward and improve patient lives. With headquarters in Dublin,
Ireland, ICON employed approximately 42,250 employees in 106
locations in 55 countries as at September 30, 2024. For further
information about ICON, visit: www.iconplc.com.
ICON/ICLR-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241223413171/en/
Claire Quinn, Corporate Communications, ICON +353 87 4066091
claire.quinn@iconplc.com Lisa Henry, Weber Shandwick (PR adviser)
+44 7785 458203 lhenry@webershandwick.com
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Nov 2024 to Dec 2024
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Dec 2023 to Dec 2024